Saturday, May 3, 2025

Scientists Launch Trial To Test Long-Acting Antibody For Long Covid

With over 65 million people suffering globally, US scientists have begun a major clinical trial to test a monoclonal antibody that may finally treat the complex mystery of Long Covid.

from Zee News :Zee News - Health https://ift.tt/NkwehuL
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Ozempic Launches In India: Doctors Reveal Weight Loss Benefits, Risks, And Who Can Use It

Ozempic has officially arrived in India at a comparatively affordable price, sparking buzz among diabetes and weight loss patients alike. Ex...